795 results on '"Chiesa C."'
Search Results
2. Conservative Management or Cesarean Hysterectomy for Placenta Accreta Spectrum: The PACCRETA Prospective Study
3. Current Status and Future Direction of Hepatic Radioembolisation
4. Clinical Profiles of Placenta Accreta Spectrum: The PACCRETA Population-based Study
5. Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship
6. 166Ho microsphere scout dose for more accurate radioembolization treatment planning
7. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity
8. NUCLEAR MEDICINE THERAPY WITH 177LU-PSMA-617 AND 177LU-DOTATATE: DOSE RATE PREDICTION AT LATE TIME FROM A SINGLE MEASUREMENT AT EARLY RELEASE TIME: A MULTICENTRIC ITALIAN STUDY
9. Preclinical signs of liver and cardiac damage in youth with metabolically healthy obese phenotype
10. A new index to simplify the screening of hypertension in overweight or obese youth
11. Recommandations pour l’administration d’oxytocine au cours du travail spontané. Texte court des recommandations
12. Does endogenous GLP-1 affect resting energy expenditure and fuel selection in overweight and obese adults?
13. White blood cell count may identify abnormal cardiometabolic phenotype and preclinical organ damage in overweight/obese children
14. CO-14.1 - NUCLEAR MEDICINE THERAPY WITH 177LU-PSMA-617 AND 177LU-DOTATATE: DOSE RATE PREDICTION AT LATE TIME FROM A SINGLE MEASUREMENT AT EARLY RELEASE TIME: A MULTICENTRIC ITALIAN STUDY
15. Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle
16. A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease
17. From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
18. The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
19. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity
20. Association of serum triglyceride-to-HDL cholesterol ratio with carotid artery intima-media thickness, insulin resistance and nonalcoholic fatty liver disease in children and adolescents
21. The Skeletonization of Milan WDS on Transients Due to Pumping Switching off: Preliminary Results
22. ICT for Efficient Water Resources Management: The ICeWater Energy Management and Control Approach
23. The Characterization of Milan WDS by Pumping Switching off: Field Test Assesment
24. Compact Buffered Routing Architecture
25. Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease
26. Upper limit of normal for alanine aminotransferase: Quo vadis?
27. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
28. Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology
29. Management of metabolic syndrome in children and adolescents
30. Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
31. Does voxel dosimetry improve clinical outcome prediction in radioembolization treatment?
32. Radioembolization of hepatocarcinoma with 90Y glass microspheres: treatment optimization using the dose-toxicity relationship
33. Radioembolization of hepatocarcinoma with 90Y glass microspheres: why predicted absorbed dose differs from actual values
34. Dosimetry in nuclear medicine for therapy optimization and exposure verification: the Italian survey
35. Comparison of mRECIST versus densitometric method for radioembolization treatment response evaluation in hepatocellular carcinoma patients
36. Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: A preliminary report
37. 1105P Predictive factors of adverse events onset in GEPNET patients treated with PRRT
38. Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity
39. Crowdfunding culture: Bridging Arts and Commerce
40. Upregulated monocyte expression of PLIN2 is associated with early arterial injury in children with overweight/obesity
41. Current Status and Future Direction of Hepatic Radioembolisation
42. EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting
43. Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
44. Joint Practice Guidelines for Radionuclide Lymphoscintigraphy for Sentinel Node Localization in Oral/Oropharyngeal Squamous Cell Carcinoma
45. Malnutricion e Inflamacion Subclinica en Pacientes en Hemodialisis Cronica: 0261
46. HD y uf en Ptes con ICC Severa e IRC III y IV Sin Respuesta al Tto Diuretico, Una Alternativa Terapeutica. A Proposito de 2 Casos: 0085
47. Hemodialisis Cronica en Ptes Que Ingresan con Mas de 75 Años. Experiencia en 4 Centros de la Pcia. de Santa Fe: 0112
48. Prospective dosimetry with 99mTc-MDP in metabolic radiotherapy of bone metastases with 153Sm-EDTMP
49. Metabolically Healthy and Unhealthy Obese Children and Adolescents
50. Clinical profiles of placenta accreta spectrum: the PACCRETA population‐based study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.